July 1, 2019 / 5:06 AM / 17 days ago

BRIEF-Cosmo Pharmaceuticals: Canadian Agency Approval Of Eleview

July 1 (Reuters) - Cosmo Pharmaceuticals NV:

*

* ELEVIEW(R) WILL BE COMMERCIALIZED IN CANADA BY PENDOPHARM (DIVISION OF PHARMASCIENCE INC.) UNDER AN EXISTING LICENSE AND SUPPLY AGREEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below